AAPL 165.84 0.5091% MSFT 400.96 0.461% GOOG 157.95 1.4321% GOOGL 156.28 1.4212% AMZN 177.23 1.4889% NVDA 795.18 4.3543% META 481.73 0.1372% TSLA 142.05 -3.4002% TSM 129.75 1.6053% LLY 731.33 0.6912% V 272.33 0.9452% AVGO 1224.46 1.6394% JPM 189.41 1.9429% UNH 491.23 -1.9755% NVO 125.26 2.0781% WMT 60.14 1.0247% LVMUY 168.89 0.4222% XOM 120.57 0.5756% LVMHF 851.89 0.4528% MA 456.75 0.2986%
Last update at 2024-04-22T20:10:00Z
Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
Income before tax | 3.89M | -10.50200M | -38.01800M | 50.13M | 1.61M |
Minority interest | 0.00000M | 2.66M | -3.55500M | -0.27900M | 0.17M |
Net income | -2.00200M | 2.62M | -19.25700M | 48.46M | 6.60M |
Selling general administrative | 449.72M | 378.33M | 287.07M | 272.73M | 226.38M |
Selling and marketing expenses | - | - | - | - | - |
Gross profit | 535.21M | 475.38M | 338.18M | 371.96M | 292.53M |
Reconciled depreciation | 24.32M | 16.41M | 12.89M | 8.10M | 6.17M |
Ebit | -18.23900M | -23.90900M | -51.83300M | 39.40M | 54.65M |
Ebitda | 6.08M | -7.50100M | -38.94200M | 47.51M | 60.82M |
Depreciation and amortization | 24.32M | 16.41M | 12.89M | 8.10M | 6.17M |
Non operating income net other | -2.32700M | -3.93900M | -0.34300M | -0.22700M | -3.60500M |
Operating income | -18.23900M | -7.50100M | -38.94200M | 47.51M | -0.85200M |
Other operating expenses | 841.05M | 755.09M | 599.35M | 499.90M | 414.95M |
Interest expense | 0.14M | 16.07M | 17.37M | 12.19M | 0.00000M |
Tax provision | 5.89M | -13.12500M | -18.76100M | 3.13M | -4.47800M |
Interest income | 0.14M | 0.94M | 1.27M | 2.85M | 2.96M |
Net interest income | 0.14M | 0.94M | 1.27M | 2.85M | 2.96M |
Extraordinary items | - | - | - | - | -0.07500M |
Non recurring | - | - | - | - | -30.83500M |
Other items | - | - | - | - | - |
Income tax expense | 5.89M | -13.12500M | -18.76100M | 3.13M | -4.40300M |
Total revenue | 847.13M | 747.59M | 560.41M | 547.40M | 444.94M |
Total operating expenses | 529.12M | 482.88M | 377.12M | 324.46M | 262.55M |
Cost of revenue | 311.93M | 272.21M | 222.24M | 175.44M | 152.41M |
Total other income expense net | 22.13M | -3.00100M | 0.92M | 2.63M | -31.33900M |
Discontinued operations | - | - | - | - | - |
Net income from continuing ops | -2.00200M | 2.62M | -19.25700M | 47.00M | 2.91M |
Net income applicable to common shares | -2.00200M | 5.28M | -15.70200M | 48.46M | 6.60M |
Preferred stock and other adjustments | - | - | - | - | - |
Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
Total assets | 1370.89M | 1244.25M | 822.98M | 665.90M | 515.01M |
Intangible assets | 81.16M | 90.62M | 10.64M | 25.41M | 27.25M |
Earning assets | - | - | - | - | - |
Other current assets | 30.28M | 29.16M | 18.73M | 14.85M | 12.20M |
Total liab | 372.03M | 290.32M | 185.19M | 180.29M | 92.59M |
Total stockholder equity | 998.86M | 953.93M | 641.50M | 485.89M | 422.24M |
Deferred long term liab | 5.10M | 5.80M | - | - | 7.59M |
Other current liab | 97.14M | 99.80M | 3.00M | 4.29M | 57.89M |
Common stock | 0.04M | 0.04M | 0.04M | 0.04M | 0.03M |
Capital stock | 0.04M | 0.04M | 0.04M | 0.04M | 0.03M |
Retained earnings | 43.90M | 45.91M | 40.62M | 57.52M | 9.06M |
Other liab | 3.28M | 3.56M | 8.01M | 15.25M | 26.53M |
Good will | 166.05M | 166.39M | 8.37M | 7.66M | 7.81M |
Other assets | 77.01M | 78.68M | 138.10M | 34.25M | 33.81M |
Cash | 69.86M | 59.38M | 69.67M | 72.78M | 67.85M |
Cash and equivalents | 69.86M | 59.38M | 69.67M | 72.78M | 67.85M |
Total current liabilities | 144.93M | 123.20M | 105.93M | 91.05M | 66.06M |
Current deferred revenue | 9.16M | - | 82.80M | 63.34M | - |
Net debt | 165.91M | 114.17M | 7.61M | 9.52M | -67.85000M |
Short term debt | 11.95M | 9.98M | 6.03M | 8.31M | 0.00000M |
Short long term debt | - | - | - | - | - |
Short long term debt total | 235.77M | 173.55M | 77.28M | 82.30M | - |
Other stockholder equity | 963.04M | 910.61M | 598.30M | 430.66M | 415.08M |
Property plant equipment | 290.97M | 227.09M | 48.17M | 131.92M | 32.61M |
Total current assets | 755.70M | 681.47M | 617.70M | 463.13M | 410.73M |
Long term investments | - | - | - | - | 0.00000M |
Net tangible assets | 751.65M | 696.92M | 622.49M | 449.30M | 384.39M |
Short term investments | 118.17M | 195.50M | 195.16M | 116.61M | 133.04M |
Net receivables | 203.38M | 133.94M | 114.61M | 105.90M | 81.90M |
Long term debt | - | - | - | - | - |
Inventory | 334.01M | 263.50M | 219.53M | 152.99M | 115.74M |
Accounts payable | 26.68M | 13.42M | 14.11M | 15.11M | 8.18M |
Total permanent equity | - | - | - | - | - |
Noncontrolling interest in consolidated entity | - | - | -3.71000M | -0.27900M | 0.17M |
Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
Accumulated other comprehensive income | -8.12400M | -2.63000M | 2.54M | -2.32400M | -1.94200M |
Additional paid in capital | - | - | - | - | - |
Common stock total equity | 0.04M | 0.04M | 0.04M | 0.04M | 0.03M |
Preferred stock total equity | - | - | - | - | - |
Retained earnings total equity | 43.90M | 45.91M | 40.62M | 57.52M | 9.06M |
Treasury stock | - | - | - | - | - |
Accumulated amortization | - | - | - | - | - |
Non currrent assets other | 12.79M | 12.98M | 8.71M | 2.95M | 0.88M |
Deferred long term asset charges | - | - | - | - | - |
Non current assets total | 615.19M | 562.78M | 205.28M | 202.77M | 104.28M |
Capital lease obligations | 235.77M | 173.55M | 77.28M | 82.30M | - |
Long term debt total | 24.86M | 26.52M | 27.07M | 26.75M | 0.00000M |
Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
Investments | 74.09M | -3.07400M | -76.33300M | 18.03M | 29.63M |
Change to liabilities | 23.93M | -1.56500M | 22.95M | -13.59500M | 15.56M |
Total cashflows from investing activities | 54.79M | -21.73500M | -104.14900M | -12.71100M | -0.38500M |
Net borrowings | -1.75100M | -1.45100M | -3.41800M | -2.57000M | -0.40400M |
Total cash from financing activities | 11.62M | 0.84M | 134.92M | -8.95900M | -9.81500M |
Change to operating activities | 9.57M | 7.75M | 14.39M | 3.56M | 16.46M |
Net income | -2.00200M | 2.62M | -19.25700M | 47.00M | 2.91M |
Change in cash | 10.48M | -10.29100M | -3.10900M | 4.93M | 17.21M |
Begin period cash flow | 59.38M | 69.67M | 72.78M | 67.85M | 50.64M |
End period cash flow | 69.86M | 59.38M | 69.67M | 72.78M | 67.85M |
Total cash from operating activities | -55.66100M | 9.50M | -33.24200M | 26.65M | 28.81M |
Issuance of capital stock | 0.00000M | 0.00000M | 134.76M | 0.00000M | 0.00000M |
Depreciation | 24.32M | 16.41M | 12.89M | 8.10M | 6.17M |
Other cashflows from investing activities | 74.09M | -0.40000M | -3.06000M | -8.63600M | -20.41400M |
Dividends paid | - | - | - | - | - |
Change to inventory | -74.63100M | -51.55400M | -56.98100M | -41.40700M | -22.28800M |
Change to account receivables | -69.85700M | -21.34400M | -8.29500M | -25.02900M | -25.76200M |
Sale purchase of stock | 21.55M | 18.37M | 151.30M | 13.90M | 12.79M |
Other cashflows from financing activities | -0.39300M | -11.41800M | 3.58M | -15.37300M | -16.64200M |
Change to netincome | 43.55M | 57.18M | 24.31M | -28.38600M | 19.32M |
Capital expenditures | 19.30M | 21.18M | 24.76M | 22.11M | 9.60M |
Change receivables | -69.85700M | -21.34400M | -8.29500M | 25.03M | -25.76200M |
Cash flows other operating | -0.97400M | -9.32400M | -8.86500M | 4.00M | 33.07M |
Exchange rate changes | - | - | - | - | -1.39500M |
Cash and cash equivalents changes | 10.75M | -11.39700M | -2.47400M | -48.32200M | 17.21M |
Change in working capital | -121.79800M | -70.41900M | -51.19000M | -56.84200M | -30.26000M |
Stock based compensation | 37.38M | 65.76M | 25.54M | 21.48M | 18.42M |
Other non cash items | 4.98M | 9.22M | 17.59M | 5.08M | 38.05M |
Free cash flow | -74.95900M | -11.67800M | -57.99800M | 4.54M | 19.20M |
Sector: Healthcare Industry: Medical Devices
Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
---|---|---|---|---|---|---|---|---|
PEN Penumbra Inc |
0.28 0.14% | 203.00 | 243.94 | 88.50 | 10.03 | 8.63 | 9.56 | 107.83 |
ABT Abbott Laboratories |
-0.21 0.20% | 107.07 | 37.15 | 23.15 | 4.67 | 4.97 | 4.88 | 19.38 |
SYK Stryker Corporation |
2.25 0.69% | 327.68 | 44.07 | 24.94 | 5.51 | 6.12 | 6.05 | 25.73 |
MDT Medtronic PLC |
1.09 1.37% | 80.57 | 26.60 | 15.87 | 3.35 | 2.08 | 3.90 | 14.12 |
BSX Boston Scientific Corp |
0.69 1.02% | 68.02 | 68.17 | 24.57 | 5.85 | 4.26 | 6.46 | 26.80 |
Penumbra, Inc., together with its subsidiairies, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device, and Penumbra ENGINE brands, as well as components and accessories; neurovascular embolization coiling systems to treat patients with various sizes of aneurysms and other neurovascular lesions under the Penumbra Coil 400, POD400, PAC400, and Penumbra SMART Coil brand names; and neurovascular access systems designed to provide intracranial access for use in a range of neurovascular therapies under the Neuron, Neuron MAX, Select, BENCHMARK, BMX96, DDC, SENDit, and PX SLIM brands. It also provides neurosurgical aspiration tools for the removal of tissue and fluids under the Artemis Neuro Evacuation Device brand; aspiration-based thrombectomy systems for vascular applications under the Indigo System, Lightning, and CAT RX brand; and detachable embolic coil systems for peripheral embolization under the Ruby Coil and Ruby LP brand names. In addition, the company offers microcatheter for the delivery of detachable coils and occlusion devices under the LANTERN brand; and POD (Penumbra Occlusion Device) brand, as well as immersive 3D computer-based technology platform under the Real Immersive System brand; and a complementary device for use with Ruby Coil and POD for vessel occlusion under the Packing Coil and Packing Coil LP brands. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.
One Penumbra Place, Alameda, CA, United States, 94502
Name | Title | Year Born |
---|---|---|
Mr. Adam Elsesser | Co-Founder, Chairman, Pres & CEO | 1962 |
Dr. Arani Bose M.D. | Co-Founder & Director | 1962 |
Ms. Maggie S. Yuen | Chief Financial Officer | 1972 |
Mr. Lambert Shiu | Chief Accounting Officer | 1980 |
Ms. Johanna Roberts | Exec. VP, Gen. Counsel & Sec. | 1972 |
Ms. Lynn Rothman | Exec. VP & Chief Bus. Officer | 1961 |
Mr. Ben Sorci | Exec. VP of Operations | NA |
Mr. Pankaj Tiwari | Exec. VP & Chief Information Officer | NA |
Ms. Jee Hamlyn-Harris | Investor Relations Officer | NA |
Ms. Shruthi Narayan | Director of Marketing - Vascular | NA |
Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).